EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS‐CoV‐2

Moyra Machado Portilho, Stephane Fraga de Oliveira Tosta iD, Maysa Pellizzaro, Rosângela Oliveira Dos Anjos, Elaine Carvalho de Oliveira, Pamela Dos Santos Nascimento de Santana, Patrícia Sousa Dos Santos Moreira, Leile Camila Jacob-Nascimento, Mirela Maisa da Silva Souza, Deborah Bittencourt Mothé, Cláudia Brodskyn, Mitermayer Galvão Reis und 2 weitere

Immunity, Inflammation and Disease · 2026-04 · 14 (4)

DOI: 10.1002/iid3.70441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 26.04.2026. Verfasst von Moyra Machado Portilho und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil. Hauptthemen laut MEDLINE: Immunoglobulin G, Immunoglobulin M, Antibodies, Viral, COVID-19. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento CientÍfico e TecnolÓgico, CoordenaÇÃo de AperfeiÇoamento de Pessoal de NÍvel Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite widespread vaccination, SARS‐CoV‐2 transmission continues, and serological testing remains relevant for selected diagnostic scenarios and population‐based assessments of antibody responses. Rapid diagnostic tests (RDTs) for SARS‐CoV‐2 antibodies are attractive for field use and decentralized settings, but their diagnostic performance varies and requires independent evaluation. We assessed the performance of three commercially available lateral flow RDTs (PANBIO™ COVID‐19 IgG/IgM Rapid Test Device, Bio‐Manguinhos‐Fiocruz TR COVID‐19 (IgM‐IgG), and Bio‐Manguinhos‐Fiocruz TR DPP® COVID‐19 IgM/IgG) in Salvador, Brazil.

Methods

Using blind analyses, we evaluated 257 serum samples from RT‐PCR‐confirmed cases and 199 control samples from individuals with other febrile illnesses or healthy donors collected before and during the pandemic.

Results

Overall sensitivity for IgM or IgG detection was limited across all tests (52%–58%), while specificity was high for two assays (97%–98%) and lower for one (80%). Sensitivity peaked between 11 and 20 days after symptom onset (80%–91%) and declined thereafter. Among 75 vaccinated individuals without prior COVID‐19, antibody positivity ranged from 39% to 55%.

Conclusion

These findings indicate that the evaluated RDTs had high specificity but insufficient sensitivity for reliable clinical diagnosis or for assessing vaccination status in serological surveys. Our results support cautious use of these assays and highlight the need for more accurate and robust antibody‐based rapid tests to strengthen immunological surveillance and public health preparedness in the post‐pandemic period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GImmunoglobulin MAntibodies, ViralCOVID-19SARS-CoV-2COVID-19 Serological TestingHumansRapid Diagnostic TestsSensitivity and SpecificityFemaleBrazilMaleAdultMiddle AgedAged

Stichwörter der Autor:innen

COVID‐19IgGIgMRapid testSARS‐COV‐2serological test

Substanzen

Immunoglobulin GImmunoglobulin MAntibodies, Viral

Autor:innen und Institutionen

  • Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
  • Secretaria Municipal de Saúde de Salvador, Salvador, Brazil.
  • Escola de Medicina Veterinária e Zootecnia, Universidade Federal da Bahia, Salvador, Brazil.
  • Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.
  • Yale School of Public Health, New Haven, Connecticut, USA.

ORCID-Profile: Stephane Fraga de Oliveira Tosta

Förderung

  • Conselho Nacional de Desenvolvimento CientÍfico e TecnolÓgico
  • CoordenaÇÃo de AperfeiÇoamento de Pessoal de NÍvel Superior

Zitieren

APA

Portilho, M. M., de Oliveira Tosta, S. F., Pellizzaro, M., Dos Anjos, R. O., de Oliveira, E. C., de Santana, P. D. S. N., Dos Santos Moreira, P. S., Jacob-Nascimento, L. C., da Silva Souza, M. M., Mothé, D. B., Brodskyn, C., Reis, M. G., Cardoso, C. W., & Ribeiro, G. S. (2026). Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS‐CoV‐2. Immunity, Inflammation and Disease, 14(4). https://doi.org/10.1002/iid3.70441

Vancouver

Portilho MM, de Oliveira Tosta SF, Pellizzaro M, Dos Anjos RO, de Oliveira EC, de Santana PDSN, et al. Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS‐CoV‐2. Immunity, Inflammation and Disease. 2026;14(4). doi:10.1002/iid3.70441

BibTeX
@article{Portilho2026,
  author = {Portilho, Moyra Machado and de Oliveira Tosta, Stephane Fraga and Pellizzaro, Maysa and Dos Anjos, Rosângela Oliveira and de Oliveira, Elaine Carvalho and de Santana, Pamela Dos Santos Nascimento and Dos Santos Moreira, Patrícia Sousa and Jacob-Nascimento, Leile Camila and da Silva Souza, Mirela Maisa and Mothé, Deborah Bittencourt and Brodskyn, Cláudia and Reis, Mitermayer Galvão and Cardoso, Cristiane Wanderley and Ribeiro, Guilherme Sousa},
  title = {Performance of Three Commercial Rapid Diagnostic Tests for Detection of IgM and IgG Antibodies Against SARS‐CoV‐2},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/iid3.70441}
}
Kostenlos starten →